|
- __________
-
- U.S. Senate,
- Committee on Veterans' Affairs,
- Washington, DC, December 8, 1994.
==During the last few years, the public has become aware of several examples where U.S.
Government researchers intentionally exposed Americans to potentially dangerous substances
without their knowledge or consent. The Senate Committee on Veterans' Affairs, which I
have been privileged to chair from 1993-94, has conducted a comprehensive analysis of the
extent to which veterans participated in such research while they were serving in the U.S.
military. This resulted in two hearings, on May 6, 1994, and August 5, 1994.
==This report, written by the majority staff of the Committee, is the result of that
comprehensive investigation, and is intended to provide information for future
deliberations by the Congress. The findings and conclusions contained in this report are
those of the majority staff and do not necessarily reflect the views of the members of the
Committee on Veterans' Affairs.
==This report would not have been possible without the dedication and expertise of Dr.
Patricia Olson, who, as a Congressional Science Fellow, worked tirelessly on this
investigation and report, and the keen intelligence, energy, and commitment of Dr. Diana
Zuckerman, who directed this effort.
JOHN D. ROCKEFELLER IV, Chairman.
|
|
COMMITTEE ON VETERANS' AFFAIRS
JOHN D. ROCKEFELLER IV, West Virginia, Chairman
DENNIS DeCONCINI, Arizona FRANK H. MURKOWSKI, Alaska
GEORGE J. MITCHELL, Maine STROM THURMOND, South Carolina
BOB GRAHAM, Florida ALAN K. SIMPSON, Wyoming
DANIEL K AKAKA, Hawaii ARLEN SPECTER, Pennsylvania
THOMAS A. DASCHLE, South Dakota JAMES M. JEFFORDS, Vermont
BEN NIGHTHORSE CAMPBELL, Colorado
Jim Gottlieb, Chief Counsel / Staff Director
John H. Moseman, Minority Staff Director / Chief Counsel
Diana M. Zuckerman, Professional Staff Member
Patricia Olson, Congressional Science Fellow
|
|
-
- IS MILITARY RESEARCH HAZARDOUS TO
- VETERANS' HEALTH? LESSONS SPANNING
- HALF A CENTURY
I. INTRODUCTION
==During the last 50 years, hundreds of thousands of military personnel have been
involved in human experimentation and other intentional exposures conducted by the
Department of Defense (DOD), often without a servicemember's knowledge or consent. In some
cases, soldiers who consented to serve as human subjects found themselves participating in
experiments quite different from those described at the time they volunteered. For
example, thousands of World War II veterans who originally volunteered to "test
summer clothing" in exchange for extra leave time, found themselves in gas chambers
testing the effects of mustard gas and lewisite.1
Additionally, soldiers were sometimes ordered by commanding officers to
"volunteer" to participate in research or face dire consequences. For example,
several Persian Gulf War veterans interviewed by Committee staff reported that they were
ordered to take experimental vaccines during Operation Desert Shield or face prison.2
==The goals of many of the military experiments and exposures were very
appropriate. For example, some experiments were intended to provide important information
about how to protect U.S. troops from nuclear, biological, and chemical weapons or other
dangerous substances during wartime. In the Persian Gulf War, U.S. troops were
intentionally exposed to an investigational vaccine that was intended to protect them
against biological warfare, and they were given pyridostigmine bromide pills in an
experimental protocol intended to protect them against chemical warfare.
==However, some of the studies that have been conducted had more questionable motives.
For example, the Department of Defense (DOD) conducted numerous "man-break"
tests, exposing soldiers to chemical weapons in order to determine the exposure level that
would cause a casualty, i.e., "break a man."3
Similarly, hundreds of soldiers were subjected to hallucinogens in experimental programs
conducted by the
|
- -------------------
1Veterans at Risk: The
Health Effects of Mustard Gas and Lewisite, Pechura, C.M. & Rall, D.P. (Eds.)
Institute of Medicine, National Academy Press, Washington, DC, 1993, p. 65.
-
- 2In a survey of 150
Persian Gulf War veterans conducted by Committee staff, 15 of 17 military personnel
receiving botulinum toxoid in the Gulf War were told they could not refuse the
vaccination; 54 of 73 military personnel receiving pyridostigmine were told they could not
refuse the drug.
-
- 3Veterans at Risk, op.
cit., p. 36.
|
|
1 |
|
|
2
==DOD in participation with, or sponsored by, the CIA.4,5
These servicemembers often unwittingly participated as human subjects in tests for drugs
intended for mind-control or behavior modification, often without their knowledge or
consent. Although the ultimate goal of those experiments was to provide information that
would help U.S. military and intelligence efforts, most Americans would agree that the use
of soldiers as unwitting guinea pigs in experiments that were designed to harm them, at
least temporarily, is not ethical.
==Whether the goals of these experiments and exposures were worthy or not, these
experiences put hundred of thousands of U.S. servicemembers at risk, and may have caused
lasting harm to many individuals.
==Every year, thousands of experiments utilizing human subjects are still being conducted
by, or on behalf of the DOD Many of these ongoing experiments have very appropriate goals
such as obtaining information for preventing, diagnosing and treating various diseases and
disabilities acquired during military service Although military personnel are the logical
choice as human subjects for such research, it is questionable whether the military
hierarchy allows for individuals in subordinate positions of power to refuse to
participate in military experiments. It is also questionable whether those who
participated as human subjects in military research were given adequate information to
fully understand the potential benefits and risks of the experiments. Moreover, the
evidence suggests that they have not been adequately monitored for adverse health effects
after the experimental protocols end.
==Veterans who become ill or disabled due to
military service are eligible to receive priority access to medical care at VA
medical facilities and to receive monthly compensation checks. In order to
qualify, they must demonstrate that their illness or disability was associated
with their military service. Veterans who did not know that they were exposed
to dangerous substances while they were in the military, therefore, would not
apply for or receive the medical care or compensation that they are entitled
to. Moreover, even if they know about the exposure, it would be difficult or
impossible to prove if the military has not kept adequate records. It is
therefore crucial that the VA learn as much as possible about the potential
exposures, and that the DOD assume responsibility for providing such
information to veterans and to the VA.
|
- ------------------
4Testimony of Deanne
Siemer, general counsel, Department of Defense, hearing before the Subcommittee on Health
and Scientific Research, Committee on Human Resources, U.S. Senate, "Human Drug
Testing by the CIA, 1977," September 20-21, 1977, pp. 157-168.
-
- 5Testimony of Sidney
Gottlieb, M.D., former CIA agent, hearing before the Subcommittee on Health and Scientific
Research, Committee on Human Resources, U.S. Senate, "Human Drug Testing by the CIA.
1977," September 20-21, 1977, pp. 169-217.
|
|
|
3
II. BACKGROUND
A. CODES, DECLARATIONS, AND LAWS GOVERNING HUMAN EXPERIMENTATION
==The Nuremberg Code is a 10-point declaration governing human experimentation, developed
by the Allies after World War II in response to inhumane experiments conducted by Nazi
scientists and physicians. The Code states that voluntary and informed consent is
absolutely essential from all human subjects who participate in research, whether during
war or peace. The Code states:
-
==The person involved should have the legal capacity to give consent; should be so
situated as to be able to exercise free power of choice, without the intervention of any
element of force, fraud, deceit, duress, overreaching, or other ulterior form of
constraint or coercion; and should have sufficient knowledge and comprehension of the
elements of the subject matter involved as to enable him to make an understanding and
enlightened decision. This latter element requires that before the acceptance of an
affirmative decision by the experimental subject, there should be made known to him the
nature, duration, and purpose of the experiment; the method and means by which it is to be
conducted; all inconveniences and hazards reasonable to be expected; and the effects upon
his health and person which may possibly come from his participation in the experiments.6
==There is no provision in the Nuremberg Code that allows a country to waive informed
consent for military personnel or veterans who serve as human subjects in experiments
during wartime or in experiments that are conducted because of threat of war. However, the
DOD has recently argued that wartime experimental requirements differ from peacetime
requirements for informed consent. According to the Pentagon, "In all peacetime
applications, we believe strongly in informed consent and its ethical foundations.....But
military combat is different."7 The
DOD argued that informed consent should be waived for investigational drugs that could
possibly save a soldier's life, avoid endangerment of the other personnel in his unit, and
accomplish the combat mission.
==More than a decade after the development of the Nuremberg Code, the World Medical
Association prepared recommendations as a guide to doctors using human subjects in
biomedical research. As a result, in 1964 the Eighteenth World Medical Assembly met in
Helsinki, Finland, and adopted recommendations to be used as an ethical code by all
medical doctors conducting biomedical research with human subjects. This code, referred to
as the Declaration of Helsinki, was
|
- -------------------
6The Nuremberg Code,
from Trials of War Criminals before the Nuremberg Military Tribunals, U.S. Government
Printing Office, Washington, DC, 1948.
-
- 755 Federal Register
52,814-52,817 (December 21, 1990), "Informed Consent for Human Drugs and Biologics:
Determinations that Informed Consent is Not Feasible."
|
|
|
4
revised in 1975, 1983, and 1989.8 It
differs from the Nuremberg Code in certain important respects. The Declaration of Helsinki
distinguishes between clinical (therapeutic) and nonclinical (nontherapeutic) biomedical
research, and addresses "proxy consent" for human subjects who are legally
incompetent, such as children or adults with severe physical or mental disabilities.9
Proxy consent for legally competent military
personnel who participate in military research is not considered appropriate
under the Nuremberg Code or the Declaration of Helsinki.
==On June 18, 1991, the Federal Government announced that 16 U.S. governmental agencies
would abide by a set of regulations, referred to as the "Common Rule," designed
to protect human subjects who participate in federally funded research.10
The provisions of the "Common Rule," first promulgated for the Department of
Health and Human Services (DHHS) in 1974, described how federally funded research
involving human subjects shall be conducted. However, local Institutional Review Boards
(IRB's) may revise or exclude some or all consent elements if the research exposes
subjects to no more than "minimal risk," meaning "that the probability and
magnitude of harm or discomfort anticipated in the research are not greater in and of
themselves than those ordinarily encountered in daily life or during the performance of
routine physical or psychological examinations or tests."11
IRB's vary greatly in their interpretation of the risks of daily life.
==There are three provisions governing research funded by DHHS that are intended to
protect vulnerable populations, such as pregnant women and fetuses, prisoners, and
children.12 There are no special Federal
regulations to protect military personnel when they participate as human subjects in
federally funded research, despite logical questions about whether military personnel can
truly "volunteer" in response to a request from a superior officer.
==Current law prevents the Department of Defense from using Federal funds for research
involving the use of human experimental subjects unless the subject gives informed consent
in advance. This law applies regardless of whether the research is intended to benefit the
subject.13
|
- -------------------
8Declaration of
Helsinki, in European and Nordic Regulations and Guidelines for Good Clinical practice,
Pharmaco Dynamics Research, Inc., July 1990. The Declaration of Helsinki was amended at
the Twenty-Ninth World Medical Assembly held in Tokyo, Japan, in 1975, the Thirty-Fifth
World Medical Assembly held in Venice Italy in 1983, and the Forty-First World Medical
Assembly held in Hong Kong in 1989.
-
- 9Declaration of
Helsinki, World Medical Association, in Biomedical Ethics, Third Edition Mappes T.A. &
Zembaty, J.S., McGraw-Hill, Inc., 1991, pp. 211-213.
- 1056 Federal Register
28,002-28,032 (June 18, 1991), "Federal Policy for the Protection of Human
Subjects."
-
- 11"Research
Involving Human Subjects," statement of Robyn Y. Nishimi, Ph.D., Office of Technology
Assessment, hearing before the Subcommittee on Energy, Committee on Science Space and
Technology, U.S. House of Representatives, "Human Radiation, Experimentation, and
Gene Therapy," February 10, 1994.
-
- 1245 CFR 46
(Public Welfare), subparts B,C, and D, revised October 1, 1991.
-
- 1310 U.S.C. (Armed
Forces) and 32 U.S.C. 980 (National Guard) put limits on the use of humans as
experimental subjects.
|
|
|
5
B. MUSTARD GAS AND LEWISITE
==According to a report published by the Institute of Medicine (IOM) last year,
approximately 60,000 military personnel Were used as human subjects in the 1940's to test
two chemical agents, mustard gas and lewisite. Most of these subjects were not informed of
the nature of the experiments and never received medical followup after their
participation in the research.14
Additionally, some of these human subjects were threatened with imprisonment at Fort
Leavenworth if they discussed these experiments with anyone, including their wives,
parents, and family doctors.15 For
decades, the Pentagon denied that the research had taken place, resulting in decades of
suffering for many veterans who became ill after the secret testing. According to the 1993
IOM report, such denial by the DOD continues: "This committee discovered that an
atmosphere of secrecy still exists to some extent regarding the WWII testing programs.
Although many documents pertaining to the WWII testing programs were declassified shortly
after the war ended, others were not."16
==Based on findings from the National Academy of Sciences, the Department of Veterans
Affairs recently published a final rule to compensate veterans for disabilities or deaths
resulting from the long- term effects of inservice exposure to mustard gas and other
agents which blister the skin (these are called vesicants).17
The final rule expands coverage to veterans exposed to mustard gas under battlefield
conditions in World War I (WWI), those present at the German air raid on the harbor of
Bari, Italy (WWII), and those engaged in manufacturing and handling vesicant agents during
their military service. Thus, for the first time, VA will compensate certain veterans for
illnesses which may have been caused by their exposure to vesicants over a century ago.17
|
| |
|
C. SEVENTH-DAY ADVENTISTS
==Many experiments that tested various biological agents on human subjects, referred to
as Operation Whitecoat, were carried out at Fort Detrick, MD, in the 1950's. The human
subjects originally consisted of volunteer enlisted men. However, after the enlisted men
staged a sitdown strike to obtain more information about the dangers of the biological
tests, Seventh-Day Adventists who were conscientious objectors were recruited for the
studies.18 Because these individuals did
not believe in engaging in actual combat, they instead volunteered to be human subjects in
military research projects that tested various infectious agents. At least 2,200 military
personnel who were
|
- -------------------
14Veterans at Risk,
op. cit., pp. 3-4, 6-8, 50-52, 224-226.
-
- 15Ibid., p. 65.
-
- 16Ibid., p. 7.
-
- 17Federal Register
41,497-42,500 (August 18, 1994), "Claims Based on Chronic Effects of Exposure to
Vesicant Agents."
-
- 18Gene Wars, Military
Control Over the New Genetic Technologies, Piller, C. & Yamamoto, K.R., Beech Tree
Books, William Morrow, New York, 1988, pp 44-45, 53.
|
|
|
6
Seventh-Day Adventists volunteered for biological testing during the 1950's through the
1970's.19
==Unlike most of the studies discussed in this report Operation Whitecoat was truly
voluntary. Leaders of the Seventh-Day Adventist Church described these human subjects as
"conscientious participants," rather than "conscientious objectors,"
because they were willing to risk their lives by participating in research rather than by
fighting a war.20,21
D. DUGWAY PROVING GROUND
==Dugway Proving Ground is a military testing facility located approximately 80 miles
From Salt Lake City. For several decades Dugway has been the site of testing for various
chemical and biological agents. From 1951 through 1969, hundreds perhaps thousands of
open-air tests using bacteria and viruses that cause disease in human, animals, and plants
were conducted at Dugway.22 For example,
antigens produced by animals that had come in contact with Venezuelan equine
encephalomyelitis (VEE), a disease usually found in horses, were later found in animals
around Dugway. Prior to the identification of these substances in the Dugway vicinity, VEE
had only been identified in the rat population in Florida. Such a finding suggested that
VEE had been used in the open-air tests at Dugway or within laboratories, and transferred
to the nearby animal population.23
==In 1968, approximately 6,400 sheep died following the intentional release of a deadly
nerve gas from a plane. According to a veterinarian who evaluated the sick and dying
sheep, there was little doubt that the sheep had been poisoned with nerve gas.24 The sheep and other animals in the area had
depressed cholinesterase levels suggesting organophosphate nerve poisoning. Initially, the
Department of Defense denied any responsibility for the accident, stating that the sheep
died from organophosphate pesticides sprayed on a nearby alfalfa field. However, the nerve
agent - was identified when the poisoned sheep were autopsied, which made it clear that
the deaths were not caused by pesticides.25
Eventually, the Department of Defense reimbursed the ranchers for their animals.
|
- -------------------
19Ibid.
-
- 20Ibid.
-
- 21At least one
Seventh-Day Adventist Church has held reunions of those human subjects who participated in
Operation Whitecoat. (Phone interview by Committee staff with Dr. Frank Damazo, Frederick,
MD, March 21, 1994.)
-
- 22Hearing before the
Subcommittee on Conservation and Natural Resources, Committee on Government Operations,
U.S. House of Representatives, "Environmental Dangers of Open-Air Testing of Lethal
Chemicals," May 20-21, 1969.
-
- 23bid., pp. 6-7.
-
- 24Testimony of Dr.
D.A. Osguthorpe, veterinarian and consultant to Utah State Department of Agriculture,
hearing before the Subcommittee on Conservation and Natural Resources, Committee on
Government Operations, U.S. House of Representatives, "Environmental Dangers of
Open-Air Testing of Lethal Chemicals," May 20-21, 1969, pp 63-66.
-
- 25Ibid., pp. 64-65.
|
|
|
7
==It is unknown how many people in the surrounding vicinity were also exposed to
potentially harmful agents used in open-air tests at Dugway. In 1969, concerns were
expressed at a congressional hearing about the possible public health implications of the
VEE virus tested at Dugway.26
==Due to previous problems with dangerous organisms and chemicals, Dugway has developed
an active program of "simulant" testing. According to the Department of Defense,
simulants are harmless organisms or chemicals which do not cause disease. However, during
45 years of open-air testing, the Army has stopped using a variety simulants when they
realized they were not as safe as previously believed.27
E. RADIATION EXPOSURE
Atomic Veterans
==From 1945 to 1962, the United States conducted numerous nuclear detonation tests:
Crossroads (Bikini, Sandstone, Greenhouse, and Ivy (Eniwetok Atoll); Castle (Bikini
Atoll); Pacific Ocean 400 miles southwest of San Diego; Redwing and Hardtack I (Eniwetok
and Bikini Atolls); Argus (South Atlantic); and Dominic (Christmas Island, Johnston
Island, 400 miles west of San Diego).28
The main goal was to determine damage caused by the bombs; however, as a result, thousands
of military personnel and civilians were exposed to radioactive fallout. Similar tests
were conducted within the continental United States, including sites in New Mexico and
Nevada.29 Veterans who participated in
activities that directly exposed them to radioactive fallout are referred to as
"atomic veterans."
==Data obtained on some military personnel who were exposed to radioactive fallout were
collected after these men were unintentionally exposed. However, some atomic veterans
believe they were used as guinea pigs to determine the effects of radiation from various
distances, including those at ground zero, on human subjects. Their suspicions are
supported by a 1951 document from the Joint Panel on the Medical Aspects of Atomic
Warfare, Research and Development Board, Department of Defense, which identified general
criteria for bomb test-related "experiments" and identified 29 "specific
problems" as "legitimate basis for biomedical participation."30
|
- -------------------
26Testimony of Hon.
Richard D. McCarthy, a Representative in Congress from the State of New York, hearing
before the Subcommittee on Conservation and Natural Resources, Committee on Government
Operations, U.S. House of Representatives, "Environmental Dangers of Open-Air Testing
of Lethal Chemicals," May 20-21, 1969, pp 6-7.
-
- 27Cole, L.A.,
"Risk and biological defense program," Physicians for Social Responsibility
Quarterly, Vol 2, No. 1, March 1992, pp. 40-50.
-
- 28Compilation of Local
Fallout Data From Test Detonations 1945-1962, extracted From DASA 1251, Vol I-Oceanic U.S.
Tests, Contract No. DNA 001-79-C-0081, May 1, 1979, sponsored by the Defense Nuclear
Agency.
-
- 29Ibid.
-
- 30Secret document,
Department of Defense, Research and Development Board, Committee on Medical Sciences,
Joint Panel on the Medical Aspects of Atomic Warfare, 8th Meeting, Washington, DC,
February 24, 1951.
|
|
|
8
==The National Research Council's Committee on the Biological Effects of Ionizing
Radiation (BEIR) have prepared a series of reports to advise the U.S. Government on the
health consequences of radiation exposure.31
The first of these reports was not published until the late 1980's, decades after military
personnel were first exposed to ionizing radiation. For the last 13 years, the VA has
provided free medical care to atomic veterans who have disorders they believe to be caused
by ionizing radiation, even if there is no conclusive evidence of the cause.32
In addition, the VA provides monthly compensation to veterans who were exposed to ionizing
radiation during military service, who have illnesses that are believed to be associated
with their exposure. The lists of compensable diseases have been revised as more research
information has become available. For example, on October 11, 1994, the VA announced that
tumors of the brain and central nervous system would be considered for disability
compensation for veterans exposed to ionizing radiation.33
Radiation Releases at U.S. Nuclear Sites
==In addition to detonation testing, radioactive releases were also intentionally
conducted at U.S. nuclear sites in the years following World War II. According to the U.S.
General Accounting Office (GAO), at least l2 planned radioactive releases occurred at
three U.S. nuclear sites during 1948-1952. These tests were conducted at Oak Ridge, TN;
Dugway, UT; and Los Alamos, NM.34
Additionally, a planned release occurred at Hanford, WA, in December 1949, which has been
referred to as the Green Run test. It is not known how many civilians and military
personnel were exposed to fallout from these tests.
Other Exposures to Ionizing Radiation
I==n January 1994, the Clinton administration established a Human Radiation Interagency
Working Group to coordinate a Government- wide effort to uncover the nature and extent of
any Government- sponsored experiments on individuals involving intentional exposure to
ionizing radiation. The working group represents the Administration's response to
Secretary of Energy Hazel O'Leary's promise to comb Government files for information on
hundreds of experiments conducted on people in the 1940's and 1950's.
==To assist in identifying those people who may
have been harmed by secret experiments utilizing ionizing radiation, the
Clinton administration solicited complaints from possible victims by
installing several telephone hotlines. As of September 1994, 86 percent of the
|
- -------------------
31"Health Effects
of Exposure to Low Levels of Ionizing Radiation," BEIR V, National Research Council,
National Academy Press, Washington, DC, 1990.
-
- 32Letter from Hon.
Jesse Brown, Secretary of Veterans Affairs, to Sen. John D. Rockefeller IV, Chair, Senate
Committee on Veterans' Affairs, May 31, 1994.
-
- 33News release, Office
of Public Affairs, Department of Veterans Affairs, Washington, DC, October 11, 1994.
-
- 34Nuclear Health and
Safety, Examples of Post World War II Radiation Releases at U.S. Nuclear Sites," U.S.
General Accounting Office, November 1993, GAO/RCED-94- 51FS.
|
|
|
9
21,996 callers to the radiation hotline were veterans who believed they had
participated in various radiation "experiments.35
==A VA advisory committee has concluded that activities other than atomic weapons tests
and occupation force activities resulted in the exposure of veterans to ionizing radiation
during their military service prior to 1970.36
The committee concluded that the records for many individuals who were exposed to such
activities are inadequate or inaccessible. Additionally, the committee concluded that
information pertinent to military exposures is not always adequate to evaluate the health
risks.
F. HALLUCINOGENS
==Working with the CIA, the Department of Defense gave hallucinogenic drugs to thousands
of "volunteer" soldiers in the 1950's and 1960's. In addition to LSD, the Army
also tested quinuclidinyl benzilate, a hallucinogen code-named BZ.37
Many of these tests were conducted under the so-called MKULTRA program, established to
counter perceived Soviet and Chinese advances in brainwashing techniques. Between 1950 and
1964, the program consisted of 149 projects involving drug testing and other studies on
unwitting human subjects.38
==One test subject was Lloyd B. Gamble, who enlisted in the U.S. Air Force in 1950. In
1957, he volunteered for a special program to test new military protective clothing. He
was offered various incentives to participate in the program, including a liberal leave
policy, family visitations, and superior living and recreational facilities. However, the
greatest incentive to Mr. Gamble was the official recognition he would receive as a
career-oriented noncommissioned officer, through letters of commendation and certification
of participation in the program. During the 3 weeks of testing new clothing, he was given
two or three water-size glasses of a liquid containing LSD to drink. Thereafter, Mr.
Gamble developed erratic behavior and even attempted suicide. He did not learn that he had
received LSD as a human subject until 18 years later, as a result of congressional
hearings in 1975.39 Even then, the
Department of the Army initially denied that he had participated in the experiments,
although an official DOD publicity photograph showed him as one of the valiant
|
- -------------------
35Information from the
Office of the Assistant Secretary for Congressional Affairs, Department of Veterans
Affairs, received at the Senate Committee on Veterans' Affairs, September 21, 1994; in
Committee files.
-
- 36Letter from Hon.
Jesse Brown, Secretary of Veterans Affairs, to Sen. John D. Rockefeller IV, Chair, U.S.
Senate Committee on Veterans' Affairs, May 26, 1994.
- 37Gene Wars, op. cit.,
pp 50-51.
-
- 38Statement of David
Gries, Director, Center for the Study of Human Intelligence, CIA, hearing before the
Subcommittee on Administrative Law and Governmental Relations, Committee on the Judiciary,
U.S. House of Representatives, "Government - Sponsored Tests on Humans and Possible
Compensation for People Harmed in the Tests," February 2, 1994.
-
- 39Summary of
testimony, Lloyd B. Gamble, LSD test subject, hearing before the Subcommittee on
Administrative Law and Governmental Relations, Committee on the Judiciary, U.S. House of
Representatives, "Government-Sponsored Tests on Humans and Possible Compensation for
People Harmed in the Tests," February 2, 1994.
|
|
|
10
servicemen volunteering for "a program that was in the highest national security
interest."40
==According to Sidney Gottlieb, a medical doctor and former CIA agent, MKULTRA was
established to investigate whether and how an individual's behavior could be modified by
covert means.41 According to Dr.
Gottlieb, the CIA believed that both the Soviet Union and Communist China might be using
techniques of altering human behavior which were not understood by the United States. Dr.
Gottlieb testified that "it was felt to be mandatory and of the utmost urgency for
our intelligence organization to establish what was possible in this field on a high
priority basis." Although many human subjects were not informed or protected, Dr.
Gottlieb defended those actions by stating, "...harsh as it may seem in retrospect,
it was felt that in an issue where national survival might be concerned, such a procedure
and such a risk was a reasonable one to take.42
G. INVESTIGATIONAL DRUGS USED IN THE PERSIAN GULF WAR
==Under the Food, Drug, and Cosmetics Act, all vaccines and medical products must be
proven safe and effective by the Food and Drug Administration (FDA) in order to be sold
and distributed in the United States. This law also applies to medical products used by
the Department of Defense, even if given to U.S. troops who are stationed in other
countries.
==FDA also regulates medical products that are proven safe and effective for some uses or
with specific doses, but not for other uses or other doses. If the product is only sold at
certain doses and not others, its use at the non-approved dose would be considered
investigational. If the product is legally available for sale at the same dosage,
physicians can legally prescribe it; however, manufacturers can not advertise it for that
purpose. Such "off label" use is also considered investigational. So, for
example, a drug may be proven safe and effective to treat one kind of cancer, but be
considered investigational to treat a different disease.
==Under current law, an unapproved vaccine or investigational use of a drug could only be
administered by the DOD under an Investigational New Drug (IND) procedure.43
Under an IND, any individual who is given the investigational product must give informed
consent, i.e., must be told of the potential risks and benefits of the product, orally and
in writing, and choose freely whether or not to participate. In addition, the IND requires
that the medical product be distributed under carefully controlled conditions where safety
and effectiveness can be evaluated.
==When the Department of Defense began preparations for Desert Shield and Desert Storm in
1990, officials were extremely concerned that Iraq would use chemical and biological
weapons against the
|
- -------------------
40Ibid.
-
- 41Testimony of Sidney
Gottlieb, M.D., former CIA agent, before the Subcommittee on Health and Scientific
Research, Committee on Human Resources, U.S. Senate, "Human Drug Testing by the CIA,
1977," September 20-21, 1977, p. 169. Actual wording is "convert means,"
which we took to mean "covert means."
-
- 42Ibid., pp. 169-217.
-
- 43Federal Register
52,814-52,817 (December 21, 1990).
|
|
|
11
United States. Despite years of study and billions of dollars, the DOD lacked drugs and
vaccines that were proven safe and effective to safeguard against anticipated chemical
nerve agents and biological toxins. Therefore, DOD officials wanted to use a medication
(pyridostigmine bromide) and vaccine (botulinum toxoid) that they believed might protect
against chemical nerve agents and botulism. Because the safety and effectiveness of
pyridostigmine bromide and botulinum toxoid had not been proven for their intended use,
these products were considered investigational drugs.
==PYRIDOSTIGMINE BROMIDE is a chemical which enhances the effectiveness
of two drugs, atropine and 2-PAM, which are proven effective for the treatment of nerve
agent poisoning.44 Pyridostigmine is
also a nerve agent itself. Nerve agents exert their biological effects by binding to, and
inhibiting, the enzyme acetylcholinesterase (AChE) which normally shuts off the
neurotransmitter, acetylcholine (ACh). When levels of ACh increase, nerve impulses and
organ activity increase. When nerve and organ stimulation are excessive, death can result.
==There are two major categories of nerve agents, carbamates and organophosphate (OP)
compounds.45 German scientists developed
many of the OP compounds for warfare agents and pesticides in the 1930's and 1940's.
Examples of warfare agents include tabun, sarin, soman, and VX. Many organophosphates permanently
inhibit AChE. This permanent effect, which can only be reversed when new enzymes are
synthesized, makes OP warfare agents extremely lethal.
==Pyridostigmine bromide is a carbamate, rather than an OP compound.46
Although it is a nerve agent, pyridostigmine has a reversible effect which can
protect the AChE form permanently binding to OP compounds. When appropriate doses are
selected pyridostigmine theoretically should not cause nerve agent poisoning and should
help protect against some lethal chemical warfare.
==Efficacy. Pyridostigmine only works when taken in combination with other drugs
and only if taken before exposure to nerve gas.47
Two antidotes to nerve agents, atropine and pyridine-2-aldoxime methochloride (2-PAM), are
reportedly enhanced if pyridostigmine has already been given. Atropine and 2-PAM were
included in the nerve agent antidote kits (Mark I) which were issued to U.S. troops in the
Persian Gulf.
==In research studies, animals given pyridostigmine, atropine, and 2-PAM were more likely
to survive exposure to one chemical nerve agent, soman, than those given only atropine and
2-PAM. However pyridostigmine is unable to enter and protect the brain, so that animals
exposed to soman can still suffer convulsions despite the pyridostigmine pretreatment.48 To protect against brain damage from
ongoing seizure activity, valium may also be required following
|
- -------------------
44Sidell, F.R.,
"Clinical Considerations in Nerve Agent Intoxication," Chemical Warfare Agents,
Somani, S.M. (Ed.), Academic Press, Inc., 1992, pp. 155-194.
-
- 45Ibid.
-
- 46Ibid.
-
- 47Ibid.
-
- 48Ibid.
|
|
|
12
exposure to a warfare nerve agent. Similarly, pyridostigmine may offer little
protection against the damage caused by nerve agents in the spinal cord.49
==Safety. Pyridostigmine bromide is approved by the FDA for treating myasthenia
gravis, a neurological disease characterized by extreme weakness. This disease occurs when
individuals develop antibodies that prevent ACh from causing muscle impulses at the
neuromuscular junction. Therefore, treatment with relative high doses of pyridostigmine
increases ACh to levels that are able to overcome the "block" created by the
antibodies. An analogy might be that of a fishing pond. The two ways to increase the
number of fish caught are to increase the number of fishing poles or to increase the
number of fish in the pond.
==FDA and DOD officials claimed they were confident of the safety of pyridostigmine as an
antidote enhancer for chemical warfare protection because it would be used at a much lower
dose50 in combat than normally used for
treating patients with myasthenia gravis. However, normal patients and those with
myasthenia gravis may not respond similarly to the same dose of pyridostigmine bromide.
Whereas the dosage of pyridostigmine bromide for patients with myasthenia gravis may reach
120 mg every three hours,51 the dose for
U.S. troops was only 30 mg every 8 hours. A good analogy is the use of insulin for
diabetes mellitus; very high doses of insulin are sometimes necessary to treat diabetics,
but similar doses could be fatal for non-diabetic individuals.
==Some scientists also question whether pyridostigmine is completely safe even for
treating patients with myasthenia gravis. The proportion of patients with myasthenia
gravis that recover after surgical treatment (thymectomy) has decreased since
pyridostigmine therapy was introduced several decades ago.52
Experts speculate that whereas the problems caused by myasthenia gravis can be corrected
by surgery, pyridostigmine may cause immune damage to the neuromuscular junction that
cannot be corrected by surgery. Since the symptoms of pyridostigmine damage would be
similar to the symptoms of myasthenia gravis, any damage from the pyridostigmine would be
extremely difficult if not impossible to diagnose.
==In addition to its use for myasthenia gravis, pyridostigmine bromide has been approved
by FDA for use with surgical patients; it is administered after surgery to reverse the
effect of anesthesia, which are neuromuscular blocking agents. The dose is relatively
small (l5 mg) and not repeated. This treatment does not provide relevant information about
the safety of repeated use of pyridostigmine by
|
- -------------------
49Das Gupta, S., Bass,
K-N., Warnick, J.E. "Interaction of reversible and irreversible cholinesterase
inhibitors on the monosynaptic reflex in neonatal rats," Toxicology and Applied
Pharmacology, Vol. 99, 1989, pp. 28-36.
-
- 5055 Federal Register
52,814-52,817 (December 21, 1990).
-
- 51Drachman, D.B.
"Medical Progress, review article: Myasthenia gravis," New England Journal of
Medicine, Vol. 330, No. 25, June 23, 1994, pp. 1797-1810.
-
- 52Scadding, G.K.,
Havard, C.W.H., Lange, M.J., & Domb, I. "The long term experience of thymectomy
for myasthenia gravis," Journal of Neurology, Neurosurgery, and Psychiatry, Vol. 48,
1985, pp. 401-406.
|
|
|
13
healthy individuals, since the dosage is small and the patients have received
neuromuscular blocking agents.
==The bromide that is included in pyridostigmine bromide pills is known to sometimes
cause problems referred to as "bromide intoxication" when used for the treatment
of myasthenia gravis.53 Bromide
intoxication may cause confusion, irritability, tremor, memory loss, psychotic behavior,
ataxia, stupor, and coma. Some patients with bromide intoxication have a skin disorder of
the face and hands resembling acne. A 60 mg tablet of the commercially available
pyridostigmine bromide contains l8.4 mg bromide (30.6 percent).54,55
==FDA has not approved pyridostigmine bromide for repeated use in healthy individuals as
an antidote enhancer or for any other reason. Since it would be unethical to expose
individuals to potentially lethal chemical weapons in order to evaluate the efficacy
of pyridostigmine, this use has only been studied on animals. The product is therefore an
investigational drug when used as an antidote enhancer for treating nerve gas poisoning.
==BOTULINUM TOXOID is an unapproved vaccine that is used to protect
laboratory workers and others who are likely to be exposed to botulism. Botulism is caused
by at least one of seven neurotoxins produced by the bacteria Clostridium botulinum. When
home-canning of food was common, food poisoning was the most common cause of botulism in
the United States; the bacteria in the food produces a toxin which is eaten. Today, the
most common form of botulism occurs infants, since the bacteria that produces the toxin
can thrive in a baby's intestinal tract.
==A botulism vaccine that is intended to protect against five of seven neurotoxins
(called A,B,C,D,E) is produced by the Michigan Department of Health. This is called
pentavalent toxoid. This vaccine is not a licensed product and must be distributed as an
Investigational New Drug (IND).
==Efficacy. Desert Shield began on August 8, 1990. Since the air war did not
begin until January 16, 1991, and the ground war took place from February 24-27, 1991, the
Pentagon had several months to review the possible use of investigational drugs and
vaccines.
==In December 1990, the FDA advised the Department of Defense that it would be unable to
test the botulism vaccine for efficacy, presumably because of limited time before the
onset of the war. The FDA agreed to test the vaccine for safety, but these tests were not
completed until late January 1991. At a meeting of the Informed Consent Waiver Review
Group (ICWRG) on December 31, 1990, a representative of FDA's Center for Biologics
Evaluation and Research discussed the vaccine, explaining that the existing supply was
nearly 20 years old and consisted of three lots, stored under continuous
|
- -------------------
53Wacks, I., Oster,
J.R., Perez, G.O., & Kett, D.H. "Spurious hyperchloremia and hyperbicarbonatemia
in a patient receiving pyridostigmine bromide therapy for myasthenia gravis,"
American Journal of Kidney Diseases, Vol. XVI, No. 1, July 1990, pp. 76-79.
-
- 54Ibid.
-
- 55Mestinon is the
brand name for one form of pyridostigmine bromide available in the United States.
|
|
|
14
refrigeration.56 Given the age of
these vaccines, they were concerns about their safety.
==The recommended schedule for immunization with the pentavalent vaccine includes a
series of three initial injections at 0, 2 and 12 weeks, followed by a booster 12 months
after the first injection According to the Centers for Disease Control's Center for
Infectious Diseases, subjects given the vaccine did not have detectable antitoxin titers
after the first two shots in the initial series, which means that they were unlikely to be
protected at week 2.57 If for any reason
only two immunizations can be given, at least 4 to 8 weeks should elapse between
injections if most individuals are to be protected against the disease.58
==Safety. The Michigan Department of Health reported that 4.2 percent of
patients reported a sore arm or other local reactions to the initial series of three
shots, an 12.1 percent had local reactions to the booster shots.59
Almost 3 percent had systemic reactions such as general malaise, after either the initial
three shots or the booster shots. Because of the relatively large percentage of adverse
reactions new lots of the vaccine were manufactured in 1971. However there is no evidence
that the newer lots produced fewer adverse reactions than the older lots.
==In her review of the DOD's application for use of botulinum toxoid in the Persian Gulf,
an FDA reviewer pointed out that in 1973 the Centers for Disease Control had considered
terminating the distribution of the vaccine because of the relatively large number of
individuals who had negative reactions to it.60
The FDA reviewer also pointed out that "there are no efficacy data in humans"
and that the dose for humans was an estimate based on results from guinea pigs. In
addition, potency testing had suggested that the vaccine would not be effective against
two of the five botulism toxins.
==According to the Michigan Department of Health, the effects
of the botulism vaccine on pregnant women had not been studied prior to its use in the
Persian Gulf War.
==ANTHRAX VACCINE is an FDA-approved vaccine that is considered safe and
effective for individuals whose skin may come in contact with animal products such as
hides, hair, or bones likely to contain the anthrax infection. It is also recommended for
veterinarians and
|
- -------------------
56Minutes of meeting
of the Informed Consent Waiver Review Group (ICWRG), Food and Drug Administration,
December 31, 1990.
-
- 57Ellis, R.J.
Immunobiologic agents and drugs available from the Centers for Disease Control:
Descriptions, recommendations, adverse reactions, and serologic response. Third Edition.
Centers for Disease Control, Public Health Service, U.S. Department of Health and Human
Services, Atlanta, GA, March 1982.
-
- 58Middlebrook, J.L.
"Contributions of the U.S. Army to Botulinum Toxin Research," Botulinum and
Tetanus Neurotoxins, Das Gupta, B.R., (Ed.), Plenum Press, New York, 1993, pp. 515-519.
-
- 59Informational
material for the use of pentavalent (ABCDE) botulinum toxoid aluminum phosphate adsorbed,
Protocol #392, Centers for Disease Control, Public Health Service, U.S. Department of
Health and Human Services, May 1992.
-
- 60Review by Ann Sutton
to the IND record, November 14, 1990; in Committee files.
|
|
|
15
others who are likely to touch infected animals.61
However, the vaccine's effectiveness against inhaled anthrax is unknown.
Unfortunately, when anthrax is used as a biological weapon, it is likely to be aerosolized
and thus inhaled. Therefore, the efficacy of the vaccine against biological warfare is
unknown.
==It appears that there is only one relevant
animal study which showed that anthrax vaccine apparently provided additional
protection against relapse in monkeys exposed to inhalation anthrax and
treated with antibiotics.62
Although the results of this study suggest the vaccine might protect against anthrax that
has been sprayed, it is not sufficient to prove that anthrax vaccine is safe and effective
as used in the Persian Gulf. The vaccine should therefore be considered investigational
when used as a protection against biological warfare.
==The anthrax vaccine is given as three injections 2 weeks apart, followed by three
additional injections given 6, 12, and 18 months after the initial injection. If immunity
is to be maintained, subsequent booster injections of anthrax vaccine are recommended at
1-year intervals.63 According to the
Interagency Task Force on Persian Gulf War Illnesses, one dose provides some immunity in
85 percent of those individuals vaccinated.64
==According to the Michigan Department of Public Health which manufactures anthrax
vaccine, it is not known whether anthrax vaccine is safe for pregnant women or their
offspring.
|
- -------------------
61Informational
material for the use of anthrax vaccine adsorbed, Michigan Department of Public Health,
U.S. License No. 99, 1978.
-
- 62Friedlander, A.M.,
Welkos, S.L., Pitt, M.L.M., et al. "Postexposure prophylaxis against experimental
inhalation anthrax," Journal of Infectious Diseases, Vol. 167, 1993, pp. 1239-1242.
-
- 63Anthrax vaccine
adsorbed, package insert, Michigan Department of Public Health, Lansing, MI, 1978.
-
- 64Summary of the
issues impacting upon the health of Persian Gulf War veterans," Version 1.1, March 3,
1994.
|
| |
|
36
K. DOD
AND DVA HAVE REPEATEDLY FAILED TO PROVIDE INFORMATION AND MEDICAL FOLLOWUP TO THOSE WHO PARTICIPATE IN
MILITARY RESEARCH OR ARE ORDERED TO TAKE INVESTIGATIONAL DRUGS.
==A common theme voiced by military personnel who have participated in military research
or training exercises over the last 50 years is the lack of information about the risks
they faced and the lack of medical followup. World War II veterans frequently reported
that they heard about the adverse health effects of mustard gas and lewisite from
newspapers and television decades after they were exposed, not from the Department of
Defense or Department of Veterans Affairs. Veterans and civilians who worked at the Dugway
Proving Ground and were exposed to a variety of biological and chemical simulants began to
question the association of poor health with work as they compared information among
themselves, not because of information provided by military officials. Veterans who were
inside atomic clouds from atomic testing heard nothing at all from their government after
they returned home from duty. Similarly, soldiers who knowingly participated in military
research designed to test the effects of hallucinogens on human behavior were never given
information to explain their hallucinations and suffered from severe psychological
disorders as a result. Even today, most of those who served in the Persian Gulf indicate
they have received no followup information about the investigational drugs they received.
==It is the responsibility of DOD and VA to identify and keep track of veterans exposed
to potentially dangerous substances so that they can receive medical care if needed. Even
in situations where DOD believes an investigational drug is safe, such followup is
necessary to establish with certainty whether exposures were safe, or whether they
resulted in long-term side effects.
|
|
40
O. DOD HAS DEMONSTRATED A PATTERN
OF MISREPRESENTING THE DANGER OF VARIOUS MILITARY EXPOSURES THAT CONTINUES TODAY.
==According to Dr. Leonard Cole, professor at Rutgers University, the DOD has denied the
possibility of harm from various exposures. However, in many instances the military
belatedly recognized that some exposures may be causing disease and death.157
Such denial, however, delays the availability of medical assistance to those harmed.
==For example, the military has released chemicals and biological agents through outdoor
"open air" tests for over four decades. Some of these supposedly safe chemicals
and biological agents, referred to as simulants, were also released over populated areas
and cities.158 Although scientific
evidence suggested that the tests may have caused illnesses to exposed citizens, the Army
repeatedly claimed that these bacteria and chemicals were harmless until adverse health
effects convinced them to change the simulants used. The death of Edward .J Nevin was
associated with the release of one simulant. Serratia marcescens, over San Francisco in
1950.159 A subsequent court trial
revealed that on September 26 and 27, 1950, the Army sprayed Serratia marcescens from a
boat off the coast of San Francisco.160
On September 29, patients at the Stanford University Hospital in San Francisco began
appearing with Serratia marcescens infections. Although the judge denied the validity of
the plaintiffs' claims that the exposures were related to the death of Mr. Nevin, the
trial raised frightening questions about the selection of simulants. Serratia marcescens
is no longer used by the military as a simulant.
==Dugway Proving Ground has been a site for "open air" testing of chemical and
biological agents for decades. The purpose of the tests is to determine how the agents
spread and survive, and their effect on people and the environment. Earl Davenport is a
veteran who participated in tests at Dugway Proving Ground in Utah, first as a military
employee and later as a civilian employee. He became ill in
|
- -------------------
157Hearing, May 6,
1994; testimony of Leonard A. Cole, Ph.D., professor, Rutgers University.
-
- 158Ibid.
-
- 159San Francisco
Chronicle, December 22, 1976, page 1.
-
- 160Cole, L.A. Clouds
of Secrecy, The Army's Germ Warfare Tests Over Populated Areas, Rowman and Littlefield,
1988, pp. 75-104.
|
|
41
1984 after being exposed to a chemical simulant called DMMP (dimethyl methylphosphate).
He had been spraying the chemical into the path of a laser beam when a sudden change in
wind blew the chemical all over his face and hair before he was able to put on a
protective mask. Although he was "wheezing and coughing" the next day, and his
symptoms lasted for weeks, the Dugway Army Hospital merely gave him cough medicine and
antibiotics. The Dugway Safety Office assured him that the chemical was safe. However, by
1988, officials at Dugway had reevaluated the simulant's danger, and were becoming
concerned that DMMP could cause cancer and kidney damage.161
Mr. Davenport is currently attempting to obtain compensation for his illness from the
Department of Labor, since his exposure occurred when he was employed at Dugway as a
civilian.
==In 1992, several military personnel from the Arizona National Guard experienced
chemical burns during a summer training exercise at the Dugway Proving Grounds. According
to two physicians, a daughter from one of the guardsmen also received chemical burns when
she later handled her father's duffle bag. One of these doctors, Dr. Michael Vance, was
contacted by military officials and encouraged to modify his written findings on the
possible cause of the daughter's injury.162
He refused.
==According to scientists and doctors from the University of Utah, there is great concern
over the potential health consequences not only for military personnel who work and train
at Dugway, but also for civilians who live in a small town and on an Indian reservation
near the Proving Grounds.
==Moreover, physicians from the Utah Medical Society have complained about the lack of
information provided to the medical community about the agents that are used in Dugway,
despite repeated requests.163
==According to Dr. Cole, the use of potentially harmful chemical and biological agents
continues at Dugway even today. For example, he testified that the Army uses a simulant
called Bacillus subtilis, "which is fairly harmless in many natural conditions, [but]
is recognized as a potential source of infection and can cause serious illness in some
people when they are exposed to it in large numbers and they inhale large numbers of those
microorganisms."164
==Dr. Cole also
testified about the lack of informed consent at Dugway in recent months. For example, in November 1993, a test that was intended to evaluate whether chemical
agents could penetrate protective clothing used informed consent forms that did not
mention the chemicals.165
|
- -------------------
161Hearing, May 6,
1994; testimony of Earl P. Davenport, veteran and former employee, Dugway Proving Ground.
-
- 162Memorandum of phone
interview with Dr. Michael Vance, Good Samaritan Hospital, Phoenix, AZ, March 21, 1994; in
Committee files.
-
- 163UMA Seeks Health
and Safety Controls at Dugway," Bulletin of the Utah Medical Society, May 1992, Vol.
40, No. 5, p. 1; "UMA Joins Lawsuit Against Army," Bulletin of the Utah Medical
Society, June 1992, Vol. 40, No. 6, p. 1; in Committee files.
-
- 164Hearing, May 6,
1994; testimony of Dr. Cole.
-
- 165Ibid.
|
| |
Return to The RATS Home Page |
| |
|